Date | Time | Source | Headline | Symbol | Company |
02/05/2021 | 4:32PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/28/2021 | 6:05AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/26/2021 | 4:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/26/2021 | 9:01AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/26/2021 | 8:48AM | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/26/2021 | 8:47AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/26/2021 | 8:30AM | GlobeNewswire Inc. | BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc. | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/20/2021 | 4:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/19/2021 | 4:01PM | GlobeNewswire Inc. | Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Thera... | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/15/2021 | 4:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/13/2021 | 4:50PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/13/2021 | 4:30PM | GlobeNewswire Inc. | BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/12/2021 | 7:43AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/12/2021 | 7:32AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/12/2021 | 7:31AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/07/2021 | 4:02PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/04/2021 | 4:31PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
01/04/2021 | 7:30AM | GlobeNewswire Inc. | Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Pr... | NASDAQ:EIDX | Eidos Therapeutics Inc |
12/29/2020 | 7:31AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
12/28/2020 | 4:31PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
12/15/2020 | 9:31AM | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:EIDX | Eidos Therapeutics Inc |
12/04/2020 | 5:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EIDX | Eidos Therapeutics Inc |
11/13/2020 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EIDX | Eidos Therapeutics Inc |
11/10/2020 | 4:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EIDX | Eidos Therapeutics Inc |
11/05/2020 | 7:30AM | GlobeNewswire Inc. | BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |
11/02/2020 | 4:02PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EIDX | Eidos Therapeutics Inc |
10/30/2020 | 4:56PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EIDX | Eidos Therapeutics Inc |
10/29/2020 | 4:48PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:EIDX | Eidos Therapeutics Inc |
10/29/2020 | 4:31PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EIDX | Eidos Therapeutics Inc |
10/29/2020 | 4:30PM | GlobeNewswire Inc. | Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update | NASDAQ:EIDX | Eidos Therapeutics Inc |